NLM Digital Collections

Search

Start Over Subjects Drug and Narcotic Control ✖Remove constraint Subjects: Drug and Narcotic Control

21. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

23. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, October 2020
Subject(s):
Drug Industry
Drug and Narcotic Control
Pharmaceutical Preparations
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

25. E2B(R3) electronic transmission of Individual Case Safety Reports (ICSRs) implementation guide: data elements and message specification

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2022
Subject(s):
Adverse Drug Reaction Reporting Systems
Drug and Narcotic Control
Electronic Mail
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

26. Pain in the nation: the drug, alcohol and suicide crises and the need for a national resilience strategy

Author(s):
Segal, Laura M., author
De Biasi, Anne, author
Mueller, Jennifer May, author
May, Kendra, author
Warren, Molly, author
Publication:
Washington, DC : Trust for America's Health, November 2017
Subject(s):
Alcohol-Related Disorders -- epidemiology
Resilience, Psychological
Substance-Related Disorders -- epidemiology
Suicide -- statistics & numerical data
Adolescent
Adult
Alcohol-Related Disorders -- economics
Alcohol-Related Disorders -- mortality
Alcohol-Related Disorders -- prevention & control
Child
Child Abuse
Child Health Services
Child Welfare
Community Mental Health Services
Continental Population Groups
Cost of Illness
Drug and Narcotic Control
Education, Nonprofessional
Family
Food Assistance
Forecasting
Health Care Costs -- statistics & numerical data
Housing
Illicit Drugs
Infant
Life Expectancy
Mental Disorders
Mental Health Services
Middle Aged
Mortality -- trends
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- mortality
Opioid-Related Disorders -- prevention & control
Pain Management
Parenting
Patient Care Team
Practice Patterns, Physicians'
Pregnancy
Prisoners
Rural Population
School Health Services
State Government
Substance-Related Disorders -- economics
Substance-Related Disorders -- mortality
Substance-Related Disorders -- prevention & control
Suicide -- prevention & control
Urban Population
Humans
United States

29. Buprenorphine: an overview for clinicians

Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States